Literature DB >> 11975935

Principles and practices for treatment of cutaneous wounds with cultured skin substitutes.

Steven T Boyce1, Glenn D Warden.   

Abstract

BACKGROUND: Skin substitutes prepared from cultured skin cells and biopolymers may reduce requirements for donor skin autograft, and have been shown to be effective in treatment of excised burns, burn scars, and congenital skin lesions. DATA SOURCES: Cultured skin substitutes (CSS) generate skin phenotypes (epidermal barrier, basement membrane) in the laboratory, and restore tissue function and systemic homeostasis. Healed skin is smooth, soft and strong, but develops irregular degrees of pigmentation. Quantitative analysis demonstrates that CSS closes 67 times the area of the donor skin, compared to less than 4 times for split-thickness skin autograft.
CONCLUSIONS: CSS reduce requirements for donor skin autograft for closure of excised, full-thickness cutaneous wounds, and demonstrate qualitative outcome that is not different from meshed, split-thickness autograft. These results offer reductions in morbidity and mortality for the treatment of burns and chronic wounds, and for cutaneous reconstruction.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11975935     DOI: 10.1016/s0002-9610(02)00813-9

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  30 in total

Review 1.  Modeling tissue-specific signaling and organ function in three dimensions.

Authors:  Karen L Schmeichel; Mina J Bissell
Journal:  J Cell Sci       Date:  2003-06-15       Impact factor: 5.285

2.  [New developments in skin reconstruction - cell cultures and skin substitutes plus review of the literature].

Authors:  N Koch; P Erba; M Benathan; W Raffoul
Journal:  Ann Burns Fire Disasters       Date:  2010-09-30

Review 3.  Topical Collagen-Based Biomaterials for Chronic Wounds: Rationale and Clinical Application.

Authors:  Lisa J Gould
Journal:  Adv Wound Care (New Rochelle)       Date:  2016-01-01       Impact factor: 4.730

4.  Improved enzymatic isolation of fibroblasts for the creation of autologous skin substitutes.

Authors:  Hongjun Wang; Clemens A Van Blitterswijk; Marion Bertrand-De Haas; Arnold H Schuurman; Evert N Lamme
Journal:  In Vitro Cell Dev Biol Anim       Date:  2004 Sep-Oct       Impact factor: 2.416

Review 5.  Tissue engineering of replacement skin: the crossroads of biomaterials, wound healing, embryonic development, stem cells and regeneration.

Authors:  Anthony D Metcalfe; Mark W J Ferguson
Journal:  J R Soc Interface       Date:  2007-06-22       Impact factor: 4.118

6.  Modelling tissues in 3D: the next future of pharmaco-toxicology and food research?

Authors:  Giovanna Mazzoleni; D Di Lorenzo; N Steimberg
Journal:  Genes Nutr       Date:  2008-12-18       Impact factor: 5.523

7.  Wound healing on athymic mice with engineered skin substitutes fabricated with keratinocytes harvested from an automated bioreactor.

Authors:  Balaji Kalyanaraman; Steven T Boyce
Journal:  J Surg Res       Date:  2008-04-29       Impact factor: 2.192

Review 8.  The role of adult tissue-derived stem cells in chronic leg ulcers: a systematic review focused on tissue regeneration medicine.

Authors:  Bruno Amato; Rita Compagna; Maurizio Amato; Lucia Butrico; Francesco Fugetto; Mariia D Chibireva; Andrea Barbetta; Marco Cannistrà; Stefano de Franciscis; Raffaele Serra
Journal:  Int Wound J       Date:  2015-09-24       Impact factor: 3.315

9.  Blockade of thrombospondin-1-CD47 interactions prevents necrosis of full thickness skin grafts.

Authors:  Jeff S Isenberg; Loretta K Pappan; Martin J Romeo; Mones Abu-Asab; Maria Tsokos; David A Wink; William A Frazier; David D Roberts
Journal:  Ann Surg       Date:  2008-01       Impact factor: 12.969

10.  A comparative study of the in vitro permeation characteristic of sulphadiazine across synthetic membranes and eschar tissue.

Authors:  Behzad Sharif Makhmal Zadeh; Hamidreza Moghimi; Paulo Santos; Jonathan Hadgraft; Majella E Lane
Journal:  Int Wound J       Date:  2008-12       Impact factor: 3.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.